Journey Medical Corp (DERM)
5.06
-0.09
(-1.75%)
USD |
NASDAQ |
Nov 14, 16:00
5.06
0.00 (0.00%)
After-Hours: 16:55
Journey Medical Revenue (Quarterly): 14.86M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 14.86M |
March 31, 2024 | 13.03M |
December 31, 2023 | 15.26M |
September 30, 2023 | 34.54M |
June 30, 2023 | 17.17M |
March 31, 2023 | 12.21M |
December 31, 2022 | 15.97M |
September 30, 2022 | 16.12M |
June 30, 2022 | 18.29M |
Date | Value |
---|---|
March 31, 2022 | 23.30M |
December 31, 2021 | 17.52M |
September 30, 2021 | 19.61M |
June 30, 2021 | 15.29M |
March 31, 2021 | 10.72M |
December 31, 2020 | 13.72M |
September 30, 2020 | 9.447M |
June 30, 2020 | 9.415M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
9.415M
Minimum
Jun 2020
34.54M
Maximum
Sep 2023
16.26M
Average
15.29M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
Fortress Biotech Inc | 14.90M |
Heron Therapeutics Inc | 36.02M |
Checkpoint Therapeutics Inc | 0.041M |
Avenue Therapeutics Inc | -- |
Eton Pharmaceuticals Inc | 9.074M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -3.361M |
Total Expenses (Quarterly) | 17.78M |
EPS Diluted (Quarterly) | -0.17 |
Enterprise Value | 102.58M |
Gross Profit Margin (Quarterly) | 55.97% |
Profit Margin (Quarterly) | -22.63% |
Earnings Yield | -0.40% |
Operating Earnings Yield | 2.10% |
Normalized Earnings Yield | -0.2467 |